MedPath

Efficacy of Unani formulation in Iron Deficiency Anaemia

Phase 2
Conditions
Health Condition 1: D509- Iron deficiency anemia, unspecified
Registration Number
CTRI/2024/06/069074
Lead Sponsor
ational Institute Of Unani Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Subjects with Haemoglobin less than or equal to 11g/dl to greater than or equal to 6g/dl

2. Age from 18-65 years

3. All Genders

Exclusion Criteria

1. Subjects with very severe anaemia haemoglobin less than 6g/dl.

2. Subjects taking medication for iron deficiency anemia, with a history of allergy to herbal medicines.

3. Subjects with uncontrolled hypertension, cardiovascular complications, with hepatic abnormality, or renal diseases.

4. Pregnant and lactating women.

5. Subjects with causes other than iron deficiency anaemia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath